Novel paradigms for drug discovery: computational multitarget screening.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  2008-02-01

• Fields of study

  Chemistry, Medicine, Computer Science, Biology

• Identifiers
  DOI 10.1016/j.tips.2007.11.007PMID 18190973PMCID PMC4551513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Author ' s personal copy

  2009cited by this paper
• Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients

  2007cited by this paper
• Pharmacogenetics of the Cytochrome P450 Enzyme System: Review of Current Knowledge and Clinical Significance

  2007cited by this paper
• Rappertk: a versatile engine for discrete restraint-based conformational sampling of macromolecules

  2007cited by this paper
• Cost-Effectiveness of Cotrimoxazole Prophylaxis Among Persons With HIV in Uganda

  2007cited by this paper
• Identification of potential HIV-1 targets of minocycline

  2007cited by this paper
• Heparin-Mimicking Sulfonic Acid Polymers as Multitarget Inhibitors of Human Immunodeficiency Virus Type 1 Tat and gp120 Proteins

  2007cited by this paper
• Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.

  2006cited by this paper
• Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel

  2006cited by this paper
• Can we rationally design promiscuous drugs?

  2006cited by this paper
• A Novel Search Engine for Virtual Screening of Very Large Databases

  2006cited by this paper
• Current development of mTOR inhibitors as anticancer agents

  2006cited by this paper
• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

  2006cited by this paper
• The cost of antiretroviral drugs and influence on prescribing policies

  2006cited by this paper
• Searching for New Antimalarial Therapeutics amongst Known Drugs

  2006influential reference
• Fumagillin suppresses HIV‐1 infection of macrophages through the inhibition of Vpr activity

  2006cited by this paper
• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

  2006cited by this paper
• Limitations of a Simplification Antiretroviral Strategy for HIV-Infected Patients with Decreasing Adherence to a Protease Inhibitor Regimen

  2006cited by this paper
• Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector

  2006cited by this paper
• A clinical drug library screen identifies astemizole as an antimalarial agent

  2006cited by this paper
• Identification of potential multitarget antimalarial drugs.

  2005cited by this paper
• Heptad-Repeat-2 Mutations Enhance the Stability of the Enfuvirtide-Resistant HIV-1 gp41 Hairpin Structure

  2005cited by this paper
• Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo*

  2005cited by this paper
• Prediction of HIV-1 Protease Inhibitor Resistance using a Protein–Inhibitor Flexible Docking Approach

  2005cited by this paper
• Structural Evolution of the Protein Kinase–Like Superfamily

  2005cited by this paper
• Kernels for small molecules and the prediction of mutagenicity, toxicity and anti-cancer activity

  2005cited by this paper
• PIRSpred: a web server for reliable HIV-1 protein-inhibitor resistance/susceptibility prediction.

  2005cited by this paper
• Computational chemistry as an integral component of lead generation.

  2005cited by this paper
• Specific inhibition of hepatitis C virus replication by cyclosporin A

  2005cited by this paper
• The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.

  2004cited by this paper
• Virtual screening of chemical libraries

  2004cited by this paper
• Improved accuracy of HIV-1 genotypic susceptibility interpretation using a consensus approach.

  2004cited by this paper
• Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.

  2004cited by this paper
• Treatment for adult HIV infection.

  2004cited by this paper
• Prediction of toxicity from chemical structure

  2004cited by this paper
• Specific inhibition of hepatitis C virus replication by cyclosporin A.

  2004cited by this paper
• Progress in toxinformatics: the challenge of predicting acute toxicity.

  2003cited by this paper
• HIV‐1 integrase inhibitory substances from Coleus parvifolius

  2003cited by this paper
• In silico prediction of drug toxicity

  2003cited by this paper
• Designing safer drugs: (Q)SAR-based identification of mutagens and carcinogens.

  2003cited by this paper
• Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei

  2003cited by this paper
• Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties.

  2003cited by this paper
• Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations

  2003cited by this paper
• Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis

  2003cited by this paper
• Computer automated prediction of potential therapeutic and toxicity protein targets of bioactive compounds from Chinese medicinal plants.

  2002cited by this paper
• Angiogenesis Inhibitors Specific for Methionine Aminopeptidase 2 as Drugs for Malaria and Leishmaniasis

  2002cited by this paper
• Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria

  2002cited by this paper
• Computer systems for the prediction of toxicity: an update.

  2002cited by this paper
• Durhamycin A, a potent inhibitor of HIV Tat transactivation.

  2002cited by this paper
• Role of G protein and protein kinase signalling in influenza virus budding in MDCK cells.

  2002cited by this paper
• Virtual screening to enrich hit lists from high‐throughput screening: A case study on small‐molecule inhibitors of angiogenin

  2002cited by this paper
• Virtual screening: a real screening complement to high-throughput screening.

  2001cited by this paper
• Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Target Distinct Phases of Early Reverse Transcription

  2001cited by this paper
• Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

  2001cited by this paper
• The TIM‐barrel fold: a versatile framework for efficient enzymes

  2001cited by this paper
• Screening for human ADME/Tox drug properties in drug discovery.

  2001cited by this paper
• Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.

  2001cited by this paper
• New developments in anti-HIV chemotherapy

  2001cited by this paper
• Binding of cosalane--a novel highly lipophilic anti-HIV agent--to albumin and glycoprotein.

  2001cited by this paper
• Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores.

  2001cited by this paper
• COMPARISON OF IN VITRO ACTIVITIES OF AMPHOTERICIN, CLOTRIMAZOLE, ECONAZOLE, MICONAZOLE, AND NYSTATIN AGAINST FUSARIUM OXYSPORUM

  2001cited by this paper
• In Vivo Antimalarial Activity of the Beta-Carboline Alkaloid Manzamine A

  2000cited by this paper
• Comparison of the Echinocandin Caspofungin with Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in a Murine Model

  2000cited by this paper
• Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain.

  2000cited by this paper
• Antiviral effect of the combination of enviroxime and disoxaril on coxsackievirus B1 infection.

  2000cited by this paper
• SCOP: a Structural Classification of Proteins database

  2000cited by this paper
• In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria

  2000cited by this paper
• Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection.

  2000cited by this paper
• Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.

  1999cited by this paper
• The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells.

  1999cited by this paper
• Inhibitors of human immunodeficiency virus integrase.

  1999cited by this paper
• The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.

  1999cited by this paper
• Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.

  1998cited by this paper
• SCOP: a structural classification of proteins database

  1998cited by this paper
• Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins.

  1998cited by this paper
• Cyclosporin Analogs Inhibit In Vitro Growth of Cryptosporidium parvum

  1998cited by this paper
• Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro

  1997cited by this paper
• The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein

  1997cited by this paper
• Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology

  1997cited by this paper
• Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.

  1997cited by this paper
• Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

  1997cited by this paper
• Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds.

  1997cited by this paper
• Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study

  1997cited by this paper
• Membrane Fusion Induced by the HIV Type 1 Fusion Peptide: Modulation by Factors Affecting Glycoprotein 41 Activity and Potential Anti-HIV Compounds

  1997cited by this paper
• In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.

  1996influential reference
• Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A

  1996cited by this paper
• Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.

  1996cited by this paper
• Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people.

  1996cited by this paper
• Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.

  1995cited by this paper
• Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication.

  1995cited by this paper
• Susceptibility of Encephalitozoon cuniculi to several drugs in vitro

  1995cited by this paper
• Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets.

  1995cited by this paper
• TOXNET: the National Library of Medicine's toxicology database.

  1995cited by this paper
• A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.

  1995cited by this paper
• Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells.

  1994cited by this paper
• Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.

  1994cited by this paper
• Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes.

  1993cited by this paper
• Inhibitors of human immunodeficiency virus integrase.

  1993cited by this paper
• Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives.

  1993cited by this paper
• Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae

  1992cited by this paper

• Uncovering novel therapeutics for schizophrenia: a multitarget approach using the CANDO platform

  2026cites this paper
• ComplexDnet: A Network-Based Strategy to Discover Critical Targets and Screen Active Compounds for Complex Diseases.

  2025cites this paper
• Targeting the alpha-synuclein protein to treat Parkinson's disease using novel inhibitors identified using an integrated computational drug development approaches

  2025cites this paper
• Multitarget-Directed Ligands for Alzheimer’s Disease: Recent Novel MTDLs and Mechanistic Insights

  2025cites this paper
• Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms

  2025cites this paper
• Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform

  2025cites this paper
• Design and Synthesis of Red-Absorbing Fluoran Leuco Dyes Supported by Computational Screening

  2024cites this paper
• Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms

  2024cites this paper
• GENIX enables comparative network analysis of single-cell RNA sequencing to reveal signatures of therapeutic interventions

  2024cites this paper
• Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options

  2023cites this paper
• Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure–Activity Relationship Studies

  2023cites this paper
• Machine learning for synergistic network pharmacology: a comprehensive overview

  2023cites this paper
• Identification of Potential Anti‐COVID‐19 Drug Leads from Medicinal Plants through Virtual High‐Throughput Screening

  2023cites this paper
• Comparative Analysis of Association Networks Using Single-Cell RNA Sequencing Data Reveals Perturbation-Relevant Gene Signatures

  2023cites this paper
• A dual-target herbicidal inhibitor of lysine biosynthesis

  2022cites this paper
• Docking Simulation Analysis of Natural Ingredients as Anti Virus SARS-Cov-2 on Helicase Inhibitors

  2022cites this paper
• Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2?

  2022cites this paper
• Identification and virtual screening of novel umami peptides from chicken soup by molecular docking.

  2022cites this paper
• Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK

  2022cites this paper
• Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer

  2022cites this paper
• Optimal COVID-19 therapeutic candidate discovery using the CANDO platform

  2022cites this paper
• Virtual Screening of Drug-Like Compounds as Potential Inhibitors of the Dengue Virus NS5 Protein

  2022cites this paper
• Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer's Disease.

  2022cites this paper
• Machine learning & deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.

  2021cites this paper
• Identifying Protein Features and Pathways Responsible for Toxicity Using Machine Learning and Tox21: Implications for Predictive Toxicology

  2021cites this paper
• A Deep-Learning Proteomic-Scale Approach for Drug Design

  2021cites this paper
• Advances in the treatment of Chagas disease: Promising new drugs, plants and targets.

  2021cites this paper
• Artificial intelligence to deep learning: machine intelligence approach for drug discovery

  2021cites this paper
• Evaluating the performance of drug-repurposing technologies

  2021cites this paper
• The Role of Molecular Modeling and Bioinformatics in Treating a Pandemic Disease: The Case of COVID-19

  2021cites this paper
• Target identification and polypharmacology of nutraceuticals

  2021cites this paper
• Der Flaschenhals – von der Forschung zur Entwicklung

  2020cites this paper
• Entwicklung – Was gehört dazu?

  2020cites this paper
• An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors

  2020cites this paper
• Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors.

  2020cites this paper
• Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein–ligand recognition process

  2020cites this paper
• Anticandidal agent for multiple targets: the next paradigm in the discovery of proficient therapeutics/overcoming drug resistance.

  2019cites this paper
• Molecular docking and in silico studies of the physicochemical properties of potential inhibitors for the phosphotransferase system of Streptococcus mutans.

  2019cites this paper
• The stilbene derivatives, nucleosides, and nucleosides modified by stilbene derivatives.

  2019cites this paper
• Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy.

  2019cites this paper
• Fingerprinting CANDO: Increased Accuracy with Structure- and Ligand-Based Shotgun Drug Repurposing

  2019cites this paper
• Exploration of interaction scoring criteria in the CANDO platform

  2019cites this paper
• Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.

  2019cites this paper
• Computational chemoproteomics to understand the role of selected psychoactives in treating mental health indications

  2019cites this paper
• Computational Methods for Multi-Target Drug Designing Against Mycobacterium tuberculosis

  2018cites this paper
• Identifying protein subsets and features responsible for improved drug repurposing accuracies using the CANDO platform

  2018cites this paper
• Computational approaches towards kinases as attractive targets for anticancer drug discovery and development.

  2018cites this paper
• Computational Approaches in Multitarget Drug Discovery.

  2018cites this paper
• Steroids‐specific target library for steroids target prediction

  2018cites this paper
• Enzyme Classification on DUD-E Database Using Logistic Regression Ensemble (Lorens)

  2018cites this paper
• Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design

  2018cites this paper
• Every Jack has His Jill: Finding a Target forYour Combinatorial Library

  2018cites this paper
• Targeted drug delivery systems used in dentistry - A short review

  2018cites this paper
• Computational Predictions for Multi-Target Drug Design

  2018cites this paper
• Dual or multi-targeting inhibitors: The next generation anticancer agents.

  2018cites this paper
• Design of Novel Dual-Target Hits Against Malaria and Tuberculosis Using Computational Docking

  2018cites this paper
• CANDOCK: Chemical atomic network based hierarchical flexible docking algorithm using generalized statistical potentials

  2018cites this paper
• Design and computational support for the binding stability of a new CCR5/CXCR4 dual tropic inhibitor: Computational design of a CCR5/CXCR4 drug.

  2017cites this paper
• Quantitative structure-activity relationship of anti-HIV integrase and reverse transcriptase inhibitors using norm indexes

  2017cites this paper
• IN SILICO SCREENING OF ANTIMALARIAL FROM INDONESIAN MEDICINAL PLANTS DATABASE TO PLASMEPSIN TARGET

  2017cites this paper
• A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment

  2017cites this paper
• Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells

  2017cites this paper
• Approved and Experimental Small‐Molecule Oncology Kinase Inhibitor Drugs: A Mid‐2016 Overview

  2017cites this paper
• Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches.

  2017cites this paper
• The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing

  2017cites this paper
• Competitive Intelligence–based Lead Generation and Fast Follower Approaches

  2016cites this paper
• Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.

  2016cites this paper
• Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.

  2016cites this paper
• Multi-Target Drugs for Neglected Diseases.

  2016cites this paper
• Mycobacterium Cytidylate Kinase Appears to Be an Undruggable Target

  2016cites this paper
• Combating Ebola with Repurposed Therapeutics Using the CANDO Platform

  2016cites this paper
• Architecture Exploration of FPGA Based Accelerators for BioInformatics Applications

  2016cites this paper
• Editorial (Thematic Issue: Polypharmacology in Drug Discovery).

  2016cites this paper
• In Silico Prediction of Drug Side Effects

  2015cites this paper
• New horizons in antimalarial drug discovery in the last decade by chemoinformatic approaches.

  2015cites this paper
• Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions

  2015cites this paper
• A consistent cheminformatics framework for automated virtual screening

  2015cites this paper
• Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase.

  2015cites this paper
• Perspectives on tuberculosis pathogenesis and discovery of anti- tubercular drugs.

  2014cites this paper
• Protein-Ligand Inverse Screening and its Application in Biotechnology and Pharmacology

  2014cites this paper
• CANDO and the infinite drug discovery frontier.

  2014cites this paper
• In silico investigation of medicinal spectrum of imidazo-azines from the perspective of multitarget screening against malaria, tuberculosis and Chagas disease.

  2014cites this paper
• Novel dual small-molecule HIV inhibitors: scaffolds and discovery strategies.

  2014cites this paper
• Comparison of cancer cell survival triggered by microtubule damage after turning Dyrk1B kinase on and off.

  2014cites this paper
• P-glycoprotein-evading anti-tumor activity of a novel tubulin and HSP90 dual inhibitor in a non-small-cell lung cancer model.

  2014cites this paper
• Acceleration and Verification of Virtual High-throughput Multiconformer Docking

  2014cites this paper
• Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening

  2014cites this paper
• Polypharmacology and supercomputer-based docking: opportunities and challenges

  2014cites this paper
• The Promise and Challenge of Digital Biology

  2013cites this paper
• LEKI WIELOCELOWE – NOWY PARADYGMAT W PROJEKTOWANIU LEKÓW

  2013cites this paper
• Pathway-based Screening Strategy for Multitarget Inhibitors of Diverse Proteins in Metabolic Pathways

  2013cites this paper
• Synthetic Genetic Targeting of Genome Instability in Cancer

  2013cites this paper
• Das Nadelöhr – von der Forschung zur Entwicklung

  2013cites this paper
• Gardiquimod: A Toll-Like Receptor-7 Agonist That Inhibits HIV Type 1 Infection of Human Macrophages and Activated T Cells

  2013cites this paper
• Polypharmacology - foe or friend?

  2013cites this paper
• Outcome-dependent global similarity analysis of imbalanced core signaling pathways in ischemic mouse hippocampus.

  2012cites this paper
• Computational Multitarget Drug Discovery

  2012cites this paper
• CHAPTER 13 Computational Multitarget Drug Discovery

  2012cites this paper
• Development: Pharmacokinetics—Systems Biology in Health and Disease III

  2012cites this paper
• Strategic Protein Target Analysis for Developing Drugs to Stop Dental Caries

  2012cites this paper